Patent classifications
C07F9/6578
DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD
The invention provides a compound of formula (I): wherein X, Y Z, R.sup.1, R.sup.2, and X.sup.+ have any of the values described in the specification. The compounds are useful to increase plant growth and/or to increase harvest yield.
##STR00001##
DITHIOPHOSPHATE DERIVATIVES AS HYDROGEN SULFIDE RELEASE CHEMICALS FOR IMPROVING PLANT GROWTH AND CROP YIELD
The invention provides a compound of formula (I): wherein X, Y Z, R.sup.1, R.sup.2, and X.sup.+ have any of the values described in the specification. The compounds are useful to increase plant growth and/or to increase harvest yield.
##STR00001##
Phosphonium ion channel blockers and methods for use
The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: ##STR00001##
The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.
Phosphonium ion channel blockers and methods for use
The invention provides compounds of Formula (I), or pharmaceutically acceptable salts thereof: ##STR00001##
The compounds, compositions, methods and kits of the invention are useful for the treatment of pain, itch, and neurogenic inflammation.
CANNABINOID DERIVATIVES
This disclosure relates generally to cannabinoid derivatives, pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives.
CANNABINOID DERIVATIVES
This disclosure relates generally to cannabinoid derivatives, pharmaceutical compositions comprising them, and methods of using the cannabinoid derivatives.
PHOSPHAPHENALENE-GOLD(I) COMPLEXES AS CHEMOTHERAPEUTIC AGENTS AGAINST GLIOBLASTOMA
Glioblastoma is one of the most lethal brain tumors. Difficulties for the treatment of glioblastoma involve, among others, the sensitivity of the brain to drugs, the limited brain penetration of chemotherapeutic agents and the resistance of tumor cells to conventional therapies. Provided are specific phosphaphenalene-gold (I) complexes for use as a medicament, especially in the treatment of brain cancer such as glioblastoma, a pharmaceutical composition and a kit comprising such complex.
PHOSPHAPHENALENE-GOLD(I) COMPLEXES AS CHEMOTHERAPEUTIC AGENTS AGAINST GLIOBLASTOMA
Glioblastoma is one of the most lethal brain tumors. Difficulties for the treatment of glioblastoma involve, among others, the sensitivity of the brain to drugs, the limited brain penetration of chemotherapeutic agents and the resistance of tumor cells to conventional therapies. Provided are specific phosphaphenalene-gold (I) complexes for use as a medicament, especially in the treatment of brain cancer such as glioblastoma, a pharmaceutical composition and a kit comprising such complex.
Chiral phosphoramidimidates and derivatives thereof
The present invention relates to chiral phosphoramidimidates, their salts and metal complexes as well as derivatives thereof and their use as catalysts.
Chiral phosphoramidimidates and derivatives thereof
The present invention relates to chiral phosphoramidimidates, their salts and metal complexes as well as derivatives thereof and their use as catalysts.